Xenous Holdings (XITO) Enterprise Value (2016 - 2017)

Xenous Holdings (XITO) posted quarterly Enterprise Value of -$8.0 for Q1 2017, up 99.1% quarter-over-quarter from -$888.0 in Q4 2016.

Xenous Holdings (XITO) Enterprise Value (2016 - 2017) Analysis & Trends

Xenous Holdings (XITO) has reported Enterprise Value for 2 consecutive years, with -$8.0 the latest figure, recorded in Q1 2017.

In Q1 2017, Enterprise Value changed N/A year-over-year to -$8.0; the TTM figure through Mar 2017 stood at -$8.0 (changed N/A YoY), while the FY2017 annual figure was -$8.0, changed N/A from the prior year.
Enterprise Value improved to -$8.0 in Q1 2017 per XITO's latest filing, from -$888.0 in the prior quarter.
Across five years, Enterprise Value topped out at -$8.0 in Q1 2017 and bottomed at -$3168.0 in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Enterprise Value (Qtr)
1	Launch Two Acquisition	557.86 Mn	557.86 Mn	-	-250,000.00
2	Drugs Made In America Acquisition	507.00 Mn	507.00 Mn	-	-174,974.00
3	Cantor Equity Partners IV	467.55 Mn	467.55 Mn	-	-25,000.00
4	GP-Act III Acquisition	401.06 Mn	401.06 Mn	-	-10,586.00
5	Aldel Financial	397.49 Mn	397.49 Mn	-	-283,112.00
6	Gores Holdings X	381.05 Mn	380.85 Mn	-	-194,541.00
7	Agriculture & Natural Solutions Acquisition	377.29 Mn	377.04 Mn	-	-250,000.00
8	Blue Water Acquisition Corp. III	342.12 Mn	342.08 Mn	-	-32,560.00
9	Berto Acquisition	313.96 Mn	313.81 Mn	-	-147,000.00
10	Xenous Holdings	7.60 Mn	7.60 Mn	-	-

Download Data